WIRE — Revenue rose 32% YoY and Ebitda surged 50% in Q1 FY27, but Systematix remains cautious on Lupin's near-term US business outlook amid increasing competition in key products.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.